Overview
- Oklo rose about 5.5% to $126.73 on Thursday, clawing back part of Wednesday’s drop, according to Benzinga Pro data.
- The stock fell roughly 14% on Wednesday after a Financial Times report questioned a roughly $17–$20 billion valuation, noting no revenue, no federal operating license, and reliance on sodium-cooled fast reactors.
- An ARK Autonomous Tech ETF filing showed the sale of 53,353 Oklo shares earlier in the week, and Sherwood News reported notable retail outflows as the stock slid 12.3% Tuesday to $139.44.
- Recent catalysts include a pact with Europe’s newcleo and Sweden’s Blykalla, described as up to $2 billion to build advanced nuclear fuel facilities in the U.S., and reported involvement in the Pentagon’s Project Janus targeting microreactor deployments by 2028.
- Oklo says it completed an NRC pre-application assessment and plans to file a combined license application by year-end, while analysts broadly rate the stock Hold with average targets near $90–$98.